<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>Shiraz University Press</PublisherName>
				<JournalTitle>Molecular Biology Research Communications</JournalTitle>
				<Issn>2322-181X</Issn>
				<Volume>13</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2024</Year>
					<Month>03</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>The importance of examining the Hardy-Weinberg Equilibrium in genetic association studies</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>1</FirstPage>
			<LastPage>2</LastPage>
			<ELocationID EIdType="pii">7213</ELocationID>
			
<ELocationID EIdType="doi">10.22099/mbrc.2023.48386.1872</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Mostafa</FirstName>
					<LastName>Saadat</LastName>
<Affiliation>Department of  Biology, School of Science, Shiraz University, Shiraz, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2023</Year>
					<Month>09</Month>
					<Day>18</Day>
				</PubDate>
			</History>
		<Abstract>No abstract</Abstract>
<ArchiveCopySource DocType="pdf">https://mbrc.shirazu.ac.ir/article_7213_ff18ae672e9414004d425f7a8afea250.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Shiraz University Press</PublisherName>
				<JournalTitle>Molecular Biology Research Communications</JournalTitle>
				<Issn>2322-181X</Issn>
				<Volume>13</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2024</Year>
					<Month>03</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Arginine to glutamine mutation in the substrate binding region impaired the isopentenyl activity of Mycobacterium tuberculosis MiaA</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>3</FirstPage>
			<LastPage>9</LastPage>
			<ELocationID EIdType="pii">7214</ELocationID>
			
<ELocationID EIdType="doi">10.22099/mbrc.2023.47247.1825</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Smitha</FirstName>
					<LastName>Soman</LastName>
<Affiliation>School of Biotechnology, Gautam Buddha University, Gautam Budh Nagar, Greater Noida, Uttar Pradesh, India</Affiliation>

</Author>
<Author>
					<FirstName>Siya</FirstName>
					<LastName>Ram</LastName>

						<AffiliationInfo>
						<Affiliation>School of Biotechnology, Gautam Buddha University, Gautam Budh Nagar, Greater Noida, Uttar Pradesh, India</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>School of Sciences, Indira Gandhi National Open University, Maidan Garhi, New Delhi, India</Affiliation>
						</AffiliationInfo>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2023</Year>
					<Month>04</Month>
					<Day>29</Day>
				</PubDate>
			</History>
		<Abstract>tRNAs act as adaptors during protein synthesis and are chemically modified post-transcriptionally for their structural stability as well as accuracy of the translation. Hypomodifications of tRNAs are known to cause various human diseases, including cancer. Studies in bacteria and yeasts showed that levels of tRNA modifications vary under different stress conditions, enabling the organism to modulate gene expression for survival. Isopentelylation of the base 37 (i&lt;sup&gt;6&lt;/sup&gt;A37) in the anticodon stem-loop by tRNA isopentenyltransferase (MiaA) is well-conserved modification present in prokaryotes and eukaryotes. i&lt;sup&gt;6&lt;/sup&gt;A37 modification increases both the speed and fidelity of translation. A homozygous p.Arg323Gln mutation in the tRNA binding region of tRNA isopentenyltransferase reduced i&lt;sup&gt;6&lt;/sup&gt;A37 levels in humans, affecting mitochondrial translation and thereby causing neurodevelopmental disorder. In this study, we mutated the Arg residue at the conserved position to Gln in &lt;em&gt;Mycobacterium tuberculosis&lt;/em&gt; (M. tb) MiaA and analyzed the i6A modification activity of the enzyme on its target tRNAs. We found that p.Arg274Gln mutant MiaA could not modify the target tRNAs, tRNA&lt;sup&gt;Leu&lt;/sup&gt;CAA, tRNA&lt;sup&gt;Phe&lt;/sup&gt;GAA, and tRNA&lt;sup&gt;Ser&lt;/sup&gt;CGA from M. tb, confirming the role of Arg residue in tRNA binding.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">MiaA</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">DMAPP</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">SDM</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">M. tuberculosis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">i6A</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">isopentenylation</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://mbrc.shirazu.ac.ir/article_7214_7c878d8ac3462cd7c84ce129e43cacfd.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Shiraz University Press</PublisherName>
				<JournalTitle>Molecular Biology Research Communications</JournalTitle>
				<Issn>2322-181X</Issn>
				<Volume>13</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2024</Year>
					<Month>03</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Evaluation of Beclin1 and mTOR genes and p62 protein expression in breast tumor tissues of Iranian patients</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>11</FirstPage>
			<LastPage>19</LastPage>
			<ELocationID EIdType="pii">7218</ELocationID>
			
<ELocationID EIdType="doi">10.22099/mbrc.2023.47597.1837</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Maryam</FirstName>
					<LastName>Adelipour</LastName>
<Affiliation>Department of Biochemistry, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Mahshid</FirstName>
					<LastName>Naghashpour</LastName>
<Affiliation>Department of Nutrition, Shool of Medicine, Abadan University of Medical Science, Abadan, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Mohammad Reza</FirstName>
					<LastName>Roshanazadeh</LastName>
<Affiliation>Department of Biochemistry, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Hadi</FirstName>
					<LastName>Chenaneh</LastName>
<Affiliation>Department of Biochemistry, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Asma</FirstName>
					<LastName>Mohammadi</LastName>
<Affiliation>Department of Biochemistry, Shool of Medicine, Abadan University of Medical Science, Abadan, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Pegah</FirstName>
					<LastName>Pourangi</LastName>
<Affiliation>Department of Biochemistry, Shool of Medicine, Abadan University of Medical Science, Abadan, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Seyed Rouhollah</FirstName>
					<LastName>Miri</LastName>
<Affiliation>Department of surgical oncology, Cancer institute, Tehran University of Medical Science</Affiliation>

</Author>
<Author>
					<FirstName>Atefeh</FirstName>
					<LastName>Zahedi</LastName>
<Affiliation>Asadabad School of Medical Sciences, Asadabad, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Mahmood</FirstName>
					<LastName>Haghighatnezhad</LastName>
<Affiliation>Department of Biochemistry, Shool of Medicine, Abadan University of Medical Science, Abadan, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Sahar</FirstName>
					<LastName>Golabi</LastName>
<Affiliation>Department of Physiology, Shool of  Medicine, Abadan University of Medical Science, Abadan, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2023</Year>
					<Month>06</Month>
					<Day>08</Day>
				</PubDate>
			</History>
		<Abstract>Autophagy is a cellular process that plays a major role in the fate of tumor cells. Understanding the role of autophagy in cancer therapy is a major challenge, particularly for breast cancer as the sole top cause of mortality among women. In this study, we evaluated the gene expression of &lt;em&gt;mTOR&lt;/em&gt; and &lt;em&gt;Beclin1&lt;/em&gt; and the levels of p62 protein, in breast tumors and compared them to a control condition. To explore the role of autophagy in breast cancer, we acquired tumor biopsies from 41 new cases of breast cancer patients. We extracted total RNA from each biopsy and used real-time PCR to quantify &lt;em&gt;Beclin1&lt;/em&gt; and &lt;em&gt;mTOR&lt;/em&gt;-specific RNA expression. In addition, we evaluated the expression of the p62 protein in paraffin-embedded tumor tissue using the immunohistochemistry technique. The data revealed an upregulation of &lt;em&gt;Beclin1&lt;/em&gt; and a downregulation of &lt;em&gt;mTOR&lt;/em&gt; in tumor tissues compared to the control condition. The correlation between p62 expression and &lt;em&gt;Beclin1&lt;/em&gt;/&lt;em&gt;mTOR&lt;/em&gt; showed a negative and positive correlation, respectively, confirming autophagy activation in the tumor tissues. However, there was no correlation between autophagy markers and tumor size, grade and stage. The findings revealed that autophagy activation was found in breast tumor tissues, suggesting that autophagy can be a target for breast cancer therapy.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Autophagy</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Beclin-1</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Breast cancer</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">mTOR</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Tumor grade</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://mbrc.shirazu.ac.ir/article_7218_93826f2404274493d0194137ea92c2af.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Shiraz University Press</PublisherName>
				<JournalTitle>Molecular Biology Research Communications</JournalTitle>
				<Issn>2322-181X</Issn>
				<Volume>13</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2024</Year>
					<Month>03</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>MicroRNAs targeting CDKN2A gene as a potential prognostic marker in head and neck squamous cell carcinoma</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>21</FirstPage>
			<LastPage>27</LastPage>
			<ELocationID EIdType="pii">7222</ELocationID>
			
<ELocationID EIdType="doi">10.22099/mbrc.2023.48081.1853</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Sivakumar</FirstName>
					<LastName>Gopalakrishnan</LastName>
<Affiliation>Clinical Genetics Lab, Centre for Cellular and Molecular Research, Saveetha Dental College &amp; Hospital, Saveetha Institute of Medical and Technical Sciences [SIMATS], Saveetha University, Chennai, India</Affiliation>

</Author>
<Author>
					<FirstName>Anitha</FirstName>
					<LastName>Pandi</LastName>
<Affiliation>Clinical Genetics Lab, Centre for Cellular and Molecular Research, Saveetha Dental College &amp; Hospital, Saveetha Institute of Medical and Technical Sciences [SIMATS], Saveetha University, Chennai, India</Affiliation>

</Author>
<Author>
					<FirstName>Paramasivam</FirstName>
					<LastName>Arumugam</LastName>
<Affiliation>Molecular Biology Lab, Centre for Cellular and Molecular Research, Saveetha Dental College &amp; Hospital, Saveetha Institute of Medical and Technical Sciences [SIMATS], Saveetha University, Chennai, India</Affiliation>

</Author>
<Author>
					<FirstName>Vijayashree</FirstName>
					<LastName>Priyadharsini Jayaseelan</LastName>
<Affiliation>Clinical Genetics Lab, Centre for Cellular and Molecular Research, Saveetha Dental College &amp; Hospital, Saveetha Institute of Medical and Technical Sciences [SIMATS], Saveetha University, Chennai, India</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2023</Year>
					<Month>08</Month>
					<Day>13</Day>
				</PubDate>
			</History>
		<Abstract>Epigenetic factors are known to markedly influence the functions of a gene by modification of transcripts, &lt;em&gt;via&lt;/em&gt; methylation or acetylation and degradation of mRNA transcripts. The &lt;em&gt;CDKN2A&lt;/em&gt; encodes cyclin-dependent kinase inhibitor 2A, a tumour suppressor protein. Genetic and epigenetic alterations in this gene have been demonstrated in several cancer types. The non-coding RNAs with a special emphasis on microRNAs have long been explored for their potential role in the epigenetic modification of gene expression. The present study aims to identify the microRNAs targeting &lt;em&gt;CDKN2A &lt;/em&gt;gene transcripts and demonstrate their prognostic significance in head and neck squamous cell carcinoma (HNSCC). Computational approaches were employed to identify the microRNAs targeting &lt;em&gt;CDKN2A. &lt;/em&gt;The gene and protein expression profile of &lt;em&gt;CDKN2A&lt;/em&gt; was analyzed using UALCAN. A significant upregulation of &lt;em&gt;CDKN2A&lt;/em&gt; was observed in the primary tumour tissues (p=&lt;10&lt;sup&gt;-12&lt;/sup&gt;). Interestingly, the protein expression, although found to be statistically significant (p=0.0129) did not correlate well with the gene expression profile. The microRNAs targeting &lt;em&gt;CDKN2A &lt;/em&gt;were further analyzed to identify the possible reason for the decrease in protein expression. Among the 44 microRNAs targeting &lt;em&gt;CDKN2A&lt;/em&gt; gene transcripts, hsa-miR-3681-3p, hsa-miR-542-5p, hsa-miR-4519 were found to be upregulated and hsa-miR-134-5p was found to be downregulated with a significant association with survival status of HNSCC patients. The hsa-miR-542-5p was found to correlate well with the survival and hence can be considered as the key microRNA associated with HNSCC. However, further validation of this microRNA is warranted to confirm its role in the process of carcinogenesis.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Cancer</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Gene expression</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">MicroRNA</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">HNSCC</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Survival</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Novel biomarkers</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://mbrc.shirazu.ac.ir/article_7222_bea11d5fefb9ed95bd12de107294cba3.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Shiraz University Press</PublisherName>
				<JournalTitle>Molecular Biology Research Communications</JournalTitle>
				<Issn>2322-181X</Issn>
				<Volume>13</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2024</Year>
					<Month>03</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>In-silico structural analysis of Heterocephalus glaber amyloid beta: an anti-Alzheimer's peptide</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>29</FirstPage>
			<LastPage>42</LastPage>
			<ELocationID EIdType="pii">7224</ELocationID>
			
<ELocationID EIdType="doi">10.22099/mbrc.2023.48223.1862</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Ali</FirstName>
					<LastName>Javanmard</LastName>
<Affiliation>Faculty of  Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Maryam</FirstName>
					<LastName>Azimzadeh-Irani</LastName>
<Affiliation>Faculty of  Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Ghazal</FirstName>
					<LastName>Tafazzoli</LastName>
<Affiliation>Faculty of  Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Ayla</FirstName>
					<LastName>Esmaeilzadeh</LastName>
<Affiliation>Faculty of  Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Mohammad</FirstName>
					<LastName>Shirinpoor-Kharf</LastName>
<Affiliation>Faculty of  Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Seyed Mohammad Hasan</FirstName>
					<LastName>Haghayeghi</LastName>
<Affiliation>Faculty of  Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2023</Year>
					<Month>09</Month>
					<Day>02</Day>
				</PubDate>
			</History>
		<Abstract>&lt;em&gt;Heterocephalus glaber&lt;/em&gt;, known as the Naked mole-rat, has an extraordinary immunity to Alzheimer&#039;s disease. The pathological hallmark of Alzheimer’s disease is cerebral accumulations of plaques, consisting of self-aggregated amyloid beta peptides. &lt;em&gt;Homo sapiens&lt;/em&gt; and &lt;em&gt;H. glaber&lt;/em&gt; amyloid beta peptides are different in only one amino acid. Herein, computational structural analyses were carried out to determine whether plaque development in &lt;em&gt;H. glaber&lt;/em&gt; is prevented by the replacement of His13 with Arg13 in the amyloid beta peptide. AlphaFold2 was used to predict the structure of the &lt;em&gt;H. glaber&lt;/em&gt; amyloid beta peptide. HADDOCK and Hex were used to self-dock the peptides and dock ions on peptides, respectively. Illustrations were made by PyMol and ChimeraX. Using VMD, we calculated the radius of gyration. The phylogenetic analysis was conducted by Mega. The results showed an accurate structure with two alpha helices separated by a short coil for &lt;em&gt;H. glaber&lt;/em&gt;. Self-docking of the two amyloid beta peptides demonstrated a globular conformation in the &lt;em&gt;H. glaber&lt;/em&gt; dimer, implying the unlikeliness of amyloid beta peptides’ self-aggregation to form fibrillar structures. This conformational state resulted in lower electrostatic energy compared to &lt;em&gt;H. sapiens&lt;/em&gt;, contributing to &lt;em&gt;H. glaber’s&lt;/em&gt; lower tendency for fibril and, ultimately, plaque formation. Phylogenetic analysis confirmed that amyloid precursor protein is highly conserved in each taxon of rodentia and primata. This study provides insight into the connection between the structure of &lt;em&gt;H. glaber&lt;/em&gt; amyloid beta and its plaque formation properties, showing that the Arg13 in &lt;em&gt;H. glaber&lt;/em&gt; leads to fibril instability, and might prevent senile plaque accumulation.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Amyloid Beta</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Alzheimer's Disease</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Heterocephalus glaber</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">AlphaFold2</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Molecular docking</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://mbrc.shirazu.ac.ir/article_7224_ee5dc98a67e5e505c429164c5186b40c.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Shiraz University Press</PublisherName>
				<JournalTitle>Molecular Biology Research Communications</JournalTitle>
				<Issn>2322-181X</Issn>
				<Volume>13</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2024</Year>
					<Month>03</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Allele and genotype frequencies of β-lactoglobulin gene using PCR-RFLP in Algerian local cattle populations</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>43</FirstPage>
			<LastPage>49</LastPage>
			<ELocationID EIdType="pii">7227</ELocationID>
			
<ELocationID EIdType="doi">10.22099/mbrc.2023.47661.1841</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Nadjet</FirstName>
					<LastName>Boushaba</LastName>
<Affiliation>Laboratory Genetics Molecular and Cellular, Department of Molecular Genetics Applied, Faculty of Nature and Life Sciences, University of Science and Technology of Oran "Mohamed Boudiaf ", B.P 1505 El M’Naouar, 31000 Oran, Algeria</Affiliation>

</Author>
<Author>
					<FirstName>Nacera</FirstName>
					<LastName>Tabet-Aoul</LastName>
<Affiliation>Laboratory Genetics Molecular and Cellular, Department of Molecular Genetics Applied, Faculty of Nature and Life Sciences, University of Science and Technology of Oran "Mohamed Boudiaf ", B.P 1505 El M’Naouar, 31000 Oran, Algeria</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2023</Year>
					<Month>06</Month>
					<Day>17</Day>
				</PubDate>
			</History>
		<Abstract>Milk protein genetic polymorphisms are associated with economically important traits in dairy cattle. The objective of this study is to genotype a single nucleotide polymorphism (SNP) responsible for the amino acid changes in the beta-lactoglobulin (β-Lg) variants A and B on 85 unrelated DNA representing Algerian cattle populations: Chelifienne (28), Cheurfa (31) and Guelmoise (26). The method used is the PCR-RFLP (Polymerase Chain Reaction-Restriction Fragment Length Polymorphism). Genetic polymorphism was detected by digestion of PCR products amplified of exon II of β-Lg gene by with the endonuclease &lt;em&gt;Hae&lt;/em&gt;III enzyme. The results revealed that the amplified product was observed as 247 bp. Restriction digestion with &lt;em&gt;Hae&lt;/em&gt;III revealed three genotypes: AA, AB and BB. The genotypic frequencies of AA, AB and BB genotypes were 0.08, 0.41, 0.50; 0.08, 0.41, 0.50 and 0.01, 0.19, 0.56 in Chelifienne, Cheurfa and Guelmoise and respectively. Frequency of AA genotype was absent in Guelmoise population. Frequencies of A and B alleles were 0.29 and 0.71 in both Chelifienne and Cheurfa and 0.25 and 0.75 Guelmoise population. These results further confirm that Bos torus cattle are predominantly of β-Lactoglobulin B type. The Chi-square test at &lt;em&gt;p&lt;/em&gt;-value &lt; 0.05 results revealed that the Chelifienne and Cheurfa populations were in Hardy-Weinberg equilibrium and the results are not significant for the Guelmoise. This genetic information could be useful to estimate the effect of polymorphism on different milk production of Algerian bovine populations.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Algerian cattle</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">β-lactoglobulin</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Genetic Variation</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">PCR-RFLP method</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">SNP</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://mbrc.shirazu.ac.ir/article_7227_625920802c3ccb75298c5aa534994e44.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
